Mary Flowers, M.D.

Mary Flowers M.D.
FACULTY MEMBER

Mary Flowers, M.D.

Professor
Clinical Research Division, Fred Hutch

Fax: 206.667.1034
Mail Stop: D5-290

Dr. Mary Flowers is a world-renowned expert in the study and treatment of chronic graft-vs-host disease, or cGVHD, a complication of transplantation in which the donated stem cells attack the recipient's healthy tissues. Dr. Flowers helps transplant survivors and their primary care physicians manage post-treatment complications as patients recover and resume their lives. In addition to her GVHD research, Dr. Flowers studies the effectiveness of using donated lymphocytes, a type of immune cell, to treat recurrent malignancies after transplantation with donated cells.

Clinical Expertise

Management of chronic GVHD and other late effects of hematopoietic cell transplantation.

Other Appointments & Affiliations

Professor, Division of Medical Oncology, Department of Medicine
University of Washington

Director at Large
American Society for Transplantation and Cellular Therapy (ASTCT) Executive Committee

Co-Chair
Brazil/Seattle Chronic GVHD Consortium

Co-Chair
Brazilian Society of BMT Chronic GVHD and Late Effects Working Group

Co-Chair
National Institute of Health (NIH) Chronic GVHD Diagnosis and Staging Working Group

Co-Chair
Center for International Blood & Marrow Transplant Research (CIBMTR) Working Committee for Late Effects and Quality of Life

Co-Chair
ASTCT and CIBMTR Scientific Organizing Committee

Education

M.D., Centro de Ciencias da Saude da Universadiade Federal do Rio Grande do Norte, Natal, R.N., Brasil

Board Certified in Hematology, Pontifícia Universidade Catolica do Rio de Janeiro, Rio de Janeiro, R.J., Brazil

Research Interests

Dr. Flowers’ clinical research has focused on long-term outcomes after hematopoietic cell transplantation (HCT), with particular attention to studies of chronic graft-versus-host disease (GVHD), quality of life and other late events. Her research has spanned the gamut from clinical trials to registry studies to cohort studies. She has been the principal investigator or co-investigator in several interventional clinical trials including multicenter randomized studies in chronic GVHD.

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210.